PG
SRDX

PEAK6 Group’s Surmodics SRDX Stock Holding History

PEAK6 Group’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.57M Buy
28,500
+23,000
+418% +$1.06M 0.01% 1569
2018
Q1 		$209K Buy
+5,500
New +$170K ﹤0.01% 3317
2017
Q4 		– Sell
-7,500
Closed -$233K – 4753
2017
Q3 		$233K Buy
7,500
+5,700
+317% +$155K ﹤0.01% 3169
2017
Q2 		$51K Buy
+1,800
New +$43.5K ﹤0.01% 4109
2014
Q2 		– Sell
-12,000
Closed -$271K – 5096
2014
Q1 		$271K Sell
12,000
-4,400
-27% -$107K ﹤0.01% 3143
2013
Q4 		$400K Sell
16,400
-14,400
-47% -$340K ﹤0.01% 2883
2013
Q3 		$366K Buy
+30,800
New +$660K ﹤0.01% 3102

Other funds holding SRDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Group's SRDX Position: Q4 2017 in Review

PEAK6 Group sold out of Surmodics (SRDX) in Q4 2017, closing a stake of 460 shares — an estimated $14K sold.

PEAK6 Group first reported a position in SRDX in Q3 2013 and held it in 3 quarters. The position peaked at $44K in Q3 2013. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.

  • PEAK6 Group reported no remaining Surmodics position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 460 Surmodics shares in Q4 2017, an estimated $14K.
  • PEAK6 Group first reported a position in Surmodics in Q3 2013 and held it in 3 quarters.
  • PEAK6 Group's Surmodics position peaked at $44K in Q3 2013.
  • 115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.